Your browser doesn't support javascript.
loading
[Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19].
Maev, I V; Andreev, D N; Sokolov, P S; Fomenko, A К; Devkota, M K; Andreev, N G; Zaborovsky, A V.
Afiliación
  • Maev IV; Yevdokimov Moscow State University of Medicine and Dentistry.
  • Andreev DN; Yevdokimov Moscow State University of Medicine and Dentistry.
  • Sokolov PS; Yevdokimov Moscow State University of Medicine and Dentistry.
  • Fomenko AК; Yevdokimov Moscow State University of Medicine and Dentistry.
  • Devkota MK; Yevdokimov Moscow State University of Medicine and Dentistry.
  • Andreev NG; Yevdokimov Moscow State University of Medicine and Dentistry.
  • Zaborovsky AV; Yevdokimov Moscow State University of Medicine and Dentistry.
Ter Arkh ; 94(10): 1163-1170, 2022 Nov 22.
Article en Ru | MEDLINE | ID: mdl-36468990
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Probióticos / Saccharomyces boulardii / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: Ru Revista: Ter Arkh Año: 2022 Tipo del documento: Article Pais de publicación: Rusia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Probióticos / Saccharomyces boulardii / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: Ru Revista: Ter Arkh Año: 2022 Tipo del documento: Article Pais de publicación: Rusia